Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Senators press congressional leaders to address radiologist Medicare pay cut

“After three consecutive years of Medicare payment reductions, healthcare providers are at a breaking point," 32 bipartisan members of the Senate wrote recently. 

Thumbnail

Class action lawsuit claims radiologists subjected patients to ‘secret’ MRI research

Physician allegedly kept patients in scanners for extra examinations as part of a study evaluating the livers of indigenous peoples. 

Thumbnail

CMS rule proposed for 2025 offers big upsides for dually eligible individuals: Analysis

Patient advocates state the updated governance would not only integrate coverage for underserved populations but also clamp down on the “games” that Medicare Advantage plans have been known to “play” with Medicaid patients.

radiologist radiology pay compensation money dollar

Average in-network and OON payment amounts are converging in radiology

This trend was seen across radiology and emergency medicine, two specialties highly impacted by surprise billing, FAIR Health noted. 

Thumbnail

FDA warns against use of unauthorized smartwatch, smart ring devices to measure blood glucose levels

Any devices that claim to make blood glucose measurements without piercing the user's skin are associated with a heightened risk of error, the agency said. 

bipartisan house task force on artificial intelligence

In the House, a new bipartisan push to get arms around AI

The move will bring together 24 representatives—12 from each party—who will work to stimulate American AI innovation while mitigating AI-related threats.  

Thumbnail

Providers prevail in 77% of No Surprises Act payment disputes, new CMS data show

Emergency (58%) and radiology (17%) services made up most non-air ambulance payment determinations, the agency reported. 

Rapt drug trial halted

FDA halts Rapt drug trial after patient complication

Shares in the drugmaker took a hit after a case of liver failure in one study participant resulted in regulators putting an immediate pause on further dosing or enrollment in the trials.